Afuco™ Anti-CD274 ADCC Therapeutic Antibody (Atezolizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD274. Atezolizumab is a human monoclonal antibody that can be potentially used in the treatment of Cancers, non-small cell lung (NSCLC), Solid tumors, bladder, urothelial.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-418CQ |
| Pricing | Inquiry |
| Host | Human |
| Target | CD274 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, IHC, FC, IP, IF, BL |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |